BETinhibitor drugs BET proteins, a significant family of epigenetic readers, play a crucial role in regulating gene expression and are implicated in various biological processes, including cancer pathogenesis, cell cycle progression, and immune responses. These proteins are characterized by the presence of one or more bromodomain and extraterminal domain (BET) domains, which are approximately 110 amino acid protein domains that specifically recognize and bind to acetylated lysine residues. This binding capability allows BET proteins to interpret the epigenetic landscape, particularly histone modifications, thereby influencing transcriptional outputWhat are BET inhibitors and how do they work?.
The BET protein family in mammals consists of four key members: BRD2 (Bromodomain-containing protein 2), BRD3, BRD4, and BRDT (Bromodomain testis-specific).Therapeutic Targeting of BET Proteins in Sarcoma These proteins are integral to the intricate mechanisms of gene regulation. Most members of the BET protein family are ubiquitously expressed in human tissues, with BRDT being primarily localized to the testes. Their fundamental function is to act as a scaffold, recruiting transcriptional machinery to specific gene loci. This makes BET proteins play a crucial role in regulating gene transcription by bridging interactions between chromatin and the transcriptional apparatus.
One of the primary molecular functions of BET proteins is to act as an epigenetic reader. They relay signals from lysine-acetylated transcriptional factors and, notably, from acetylated histone tails. This interaction is mediated by the bromodomains, which can bind to acetylated lysines on histone proteins. This binding event is a critical step in the initiation and elongation of transcription. For instance, BRD4 is known to activate transcription in neurons and plays essential roles in various cellular processes.
Beyond their general role in gene transcription, BET proteins are crucial for normal cellular processing. They control processes such as cell cycle progression, neurogenesis, and the differentiation and maturation of erythroids. Furthermore, BET proteins are recently emerging as critical players in DNA damage repair, where they orchestrate the gene transcription of vital DNA repairing factorsBET Proteins: An Approach to Future Therapies in .... Their involvement extends to immune responses, where they influence inflammatory gene transcription, making them relevant in conditions like transplant rejection. The intricate roles of BET proteins underscore their significance in maintaining cellular homeostasis and responding to various cellular cues.BET proteins: Biological functions and therapeutic ...
The deregulated activity of BET proteins has been strongly linked to the development and progression of various diseases, most notably cancer. Their role in promoting oncogenic transcription and cell proliferation has made them attractive therapeutic targets. This has led to the development of BET inhibitors, a class of drugs designed to block the interaction between BET proteins and their acetylated targetsBromodomain and extraterminal domain (BET) proteinsare epigenetic readers that regulate gene expression and are involved in cancer pathogenesis.. These BET inhibitors reversibly bind to the bromodomains of BRD2, BRD3, BRD4, and BRDT.作者：DB Doroshow·2017·被引用次数：438—BET proteins have multiple functions, including the initiation and elongation of transcription and cell cycle regulation. In recent years, inhibitors of BET ...
While BET inhibitors show promise, their clinical application is an evolving field.Functions of BET proteins in erythroid gene expression | Blood Studies have indicated that BETis generally cause modest anticancer activity, predominantly through cytostatic effects, and can evoke dose-limiting toxicities (DLTs) and adaptive responses in patients. Nevertheless, the therapeutic potential of targeting BET proteins for conditions ranging from cancer to immune diseases and other disorders continues to be explored. BET inhibitors are being evaluated for the treatment of cancer and other diseases, with ongoing BET inhibitor clinical trial efforts aiming to refine their efficacy and reduce side effectsBET Proteins as Attractive Targets for Cancer Therapeutics. While no BET inhibitor FDA approved drugs are currently available for widespread use, research is actively progressing, with compounds like JQ1 BET inhibitor serving as valuable tool compounds in preclinical studies.作者：N Wang·2021·被引用次数：303—The BET family contains four related proteins (namelyBRD2, BRD3, BRD4, and BRDT) that act as epigenetic readers with broad specificity on ...
It is important to differentiate BET proteins from other entities with similar phonetic names. For example, "bet" can also refer to a wager or a specific type of hedging strategy in biological contexts, as seen with "growth-dependent sensory bet-hedging." Furthermore, "protein powders" are unrelated dietary supplements, with brands like Optimum Nutrition Gold Standard Whey Protein being common examples in the fitness industry, distinct from the cellular functions of BET proteins. Similarly, "Betamethasone Topical" is a corticosteroid medication used for skin conditions and is entirely separate from the biological role of BET proteins.
In summary, BET proteins represent a vital class of epigenetic regulators with broad implications in cellular function and disease. Their ability to interpret histone acetylation marks positions them at the crossroads of gene regulation, cell cycle control, and immune response. The development of BET inhibitors offers a novel epigenetic approach to therapeutic intervention, particularly in oncology, and continued research into their complex biology promises to unlock further treatment strategies for a range of human diseases. The ongoing investigation into the biological functions and therapeutic interventions related to BET proteins highlights their significant potential in modern medicine.
Join the newsletter to receive news, updates, new products and freebies in your inbox.